Kevin Ess
Concepts (317)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberous Sclerosis | 19 | 2019 | 36 | 4.540 |
Why?
| Tumor Suppressor Proteins | 13 | 2023 | 282 | 3.450 |
Why?
| TOR Serine-Threonine Kinases | 10 | 2023 | 358 | 1.630 |
Why?
| Induced Pluripotent Stem Cells | 12 | 2020 | 182 | 1.570 |
Why?
| Sirolimus | 6 | 2018 | 181 | 1.110 |
Why?
| Astrocytoma | 3 | 2021 | 108 | 1.100 |
Why?
| Neural Stem Cells | 7 | 2019 | 115 | 1.070 |
Why?
| Tumor Suppressor Protein p53 | 5 | 2017 | 445 | 1.050 |
Why?
| Neurons | 8 | 2020 | 1279 | 1.010 |
Why?
| Multiprotein Complexes | 4 | 2013 | 140 | 0.960 |
Why?
| Signal Transduction | 14 | 2023 | 4509 | 0.900 |
Why?
| Epilepsy | 5 | 2021 | 277 | 0.890 |
Why?
| Mechanistic Target of Rapamycin Complex 1 | 7 | 2023 | 96 | 0.880 |
Why?
| Hemiplegia | 2 | 2020 | 18 | 0.850 |
Why?
| Brain | 8 | 2015 | 2371 | 0.850 |
Why?
| Zebrafish | 6 | 2023 | 411 | 0.850 |
Why?
| Sodium-Potassium-Exchanging ATPase | 2 | 2020 | 43 | 0.840 |
Why?
| Cell Differentiation | 9 | 2020 | 1700 | 0.780 |
Why?
| Epilepsy, Generalized | 1 | 2021 | 13 | 0.760 |
Why?
| Mosaicism | 1 | 2021 | 60 | 0.740 |
Why?
| White Matter | 4 | 2017 | 104 | 0.730 |
Why?
| Loss of Heterozygosity | 1 | 2017 | 40 | 0.590 |
Why?
| Neurogenesis | 3 | 2017 | 102 | 0.580 |
Why?
| Brain Neoplasms | 2 | 2021 | 979 | 0.580 |
Why?
| Autistic Disorder | 1 | 2019 | 162 | 0.560 |
Why?
| Cellular Reprogramming | 1 | 2017 | 84 | 0.560 |
Why?
| Autism Spectrum Disorder | 1 | 2021 | 322 | 0.550 |
Why?
| Heterozygote | 2 | 2017 | 251 | 0.540 |
Why?
| Diffusion Tensor Imaging | 2 | 2015 | 63 | 0.510 |
Why?
| Gene Deletion | 2 | 2013 | 356 | 0.460 |
Why?
| Mutation | 8 | 2019 | 3344 | 0.450 |
Why?
| Mice, Knockout | 12 | 2019 | 2565 | 0.450 |
Why?
| Zebrafish Proteins | 2 | 2013 | 246 | 0.440 |
Why?
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2013 | 2 | 0.440 |
Why?
| Electron-Transferring Flavoproteins | 1 | 2013 | 4 | 0.440 |
Why?
| Disease Models, Animal | 13 | 2017 | 3531 | 0.430 |
Why?
| Carrier Proteins | 4 | 2015 | 695 | 0.430 |
Why?
| Gene Knock-In Techniques | 1 | 2013 | 46 | 0.420 |
Why?
| Immunosuppressive Agents | 2 | 2019 | 646 | 0.420 |
Why?
| Regenerative Medicine | 1 | 2013 | 41 | 0.410 |
Why?
| Mitochondrial Diseases | 1 | 2013 | 77 | 0.410 |
Why?
| Everolimus | 3 | 2019 | 61 | 0.410 |
Why?
| Seizures | 4 | 2021 | 340 | 0.410 |
Why?
| Kidney Tubules, Distal | 1 | 2012 | 4 | 0.410 |
Why?
| Neuroglia | 2 | 2011 | 150 | 0.410 |
Why?
| Animals | 33 | 2023 | 31694 | 0.400 |
Why?
| Gene Silencing | 1 | 2013 | 171 | 0.400 |
Why?
| Stem Cell Transplantation | 1 | 2013 | 149 | 0.390 |
Why?
| Nerve Fibers, Myelinated | 1 | 2012 | 41 | 0.390 |
Why?
| Rapamycin-Insensitive Companion of mTOR Protein | 4 | 2017 | 28 | 0.390 |
Why?
| Corpus Callosum | 1 | 2012 | 56 | 0.390 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2015 | 386 | 0.380 |
Why?
| Astrocytes | 4 | 2019 | 162 | 0.380 |
Why?
| Mice | 22 | 2023 | 14860 | 0.370 |
Why?
| Myelin Sheath | 3 | 2017 | 144 | 0.370 |
Why?
| Cilia | 1 | 2012 | 162 | 0.360 |
Why?
| Cell Transformation, Neoplastic | 1 | 2013 | 308 | 0.360 |
Why?
| Interneurons | 1 | 2011 | 96 | 0.360 |
Why?
| Codon, Nonsense | 1 | 2010 | 37 | 0.360 |
Why?
| Nervous System Diseases | 1 | 2013 | 253 | 0.340 |
Why?
| Cerebral Cortex | 4 | 2020 | 380 | 0.330 |
Why?
| Trans-Activators | 4 | 2012 | 367 | 0.330 |
Why?
| Humans | 41 | 2023 | 114623 | 0.310 |
Why?
| Mutant Proteins | 2 | 2023 | 95 | 0.300 |
Why?
| Alleles | 3 | 2017 | 789 | 0.300 |
Why?
| Neurobiology | 1 | 2006 | 16 | 0.260 |
Why?
| Carcinogenesis | 2 | 2019 | 177 | 0.250 |
Why?
| Electroencephalography | 2 | 2021 | 362 | 0.250 |
Why?
| Child | 11 | 2021 | 18404 | 0.250 |
Why?
| Huntington Disease | 2 | 2016 | 38 | 0.250 |
Why?
| Mechanistic Target of Rapamycin Complex 2 | 3 | 2017 | 55 | 0.240 |
Why?
| Proto-Oncogene Proteins | 3 | 1999 | 608 | 0.230 |
Why?
| Cell Culture Techniques | 2 | 2019 | 342 | 0.230 |
Why?
| Cells, Cultured | 7 | 2020 | 3881 | 0.230 |
Why?
| Proteins | 4 | 2015 | 908 | 0.220 |
Why?
| Transcription Factors | 4 | 2012 | 1528 | 0.220 |
Why?
| Ubiquitin-Protein Ligases | 2 | 2014 | 139 | 0.200 |
Why?
| Mitochondria | 4 | 2015 | 747 | 0.190 |
Why?
| Embryonic and Fetal Development | 2 | 1999 | 94 | 0.190 |
Why?
| Oncogenes | 2 | 1999 | 103 | 0.190 |
Why?
| Gene Expression Profiling | 2 | 2005 | 1518 | 0.180 |
Why?
| Thymus Gland | 3 | 1999 | 296 | 0.180 |
Why?
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 1 | 0.180 |
Why?
| GTPase-Activating Proteins | 1 | 2020 | 71 | 0.170 |
Why?
| Cardiomyopathy, Dilated | 1 | 2023 | 348 | 0.170 |
Why?
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2019 | 15 | 0.170 |
Why?
| Drug Resistant Epilepsy | 1 | 2020 | 45 | 0.170 |
Why?
| Parkinson Disease | 2 | 2014 | 345 | 0.160 |
Why?
| Lateral Ventricles | 1 | 2019 | 24 | 0.160 |
Why?
| Gene Expression Regulation, Developmental | 5 | 2017 | 800 | 0.160 |
Why?
| Immunization | 1 | 2021 | 397 | 0.160 |
Why?
| Polycystic Kidney Diseases | 1 | 2019 | 55 | 0.160 |
Why?
| Aquaporin 4 | 1 | 2019 | 87 | 0.160 |
Why?
| Blood-Brain Barrier | 1 | 2019 | 106 | 0.150 |
Why?
| Male | 13 | 2021 | 55554 | 0.150 |
Why?
| Recurrence | 1 | 2021 | 935 | 0.150 |
Why?
| Wnt Signaling Pathway | 2 | 2023 | 146 | 0.150 |
Why?
| Mutation, Missense | 1 | 2020 | 293 | 0.150 |
Why?
| Female | 13 | 2023 | 59466 | 0.150 |
Why?
| Manganese | 2 | 2014 | 55 | 0.150 |
Why?
| Genes, p53 | 1 | 2017 | 61 | 0.150 |
Why?
| Membrane Potentials | 1 | 2018 | 248 | 0.140 |
Why?
| Fibrosis | 1 | 2019 | 453 | 0.140 |
Why?
| Phenotype | 3 | 2020 | 2796 | 0.140 |
Why?
| Practice Guidelines as Topic | 2 | 2021 | 1394 | 0.140 |
Why?
| Endothelial Cells | 2 | 2019 | 681 | 0.130 |
Why?
| Myocytes, Cardiac | 2 | 2023 | 449 | 0.130 |
Why?
| Infant | 6 | 2018 | 7959 | 0.130 |
Why?
| Demyelinating Diseases | 1 | 2016 | 75 | 0.130 |
Why?
| Genomic Instability | 1 | 2016 | 38 | 0.130 |
Why?
| Central Nervous System | 1 | 2017 | 235 | 0.130 |
Why?
| RNA, Small Interfering | 1 | 2017 | 535 | 0.130 |
Why?
| Magnetic Resonance Imaging | 2 | 2016 | 3039 | 0.120 |
Why?
| Polyesters | 1 | 2015 | 64 | 0.120 |
Why?
| Gene Knockdown Techniques | 1 | 2016 | 299 | 0.120 |
Why?
| Child, Preschool | 6 | 2019 | 9108 | 0.120 |
Why?
| Chromatin | 2 | 2015 | 428 | 0.120 |
Why?
| Cell Line | 6 | 2015 | 2635 | 0.120 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 63 | 0.120 |
Why?
| Neuroimaging | 1 | 2016 | 249 | 0.120 |
Why?
| Enhancer Elements, Genetic | 1 | 1995 | 151 | 0.120 |
Why?
| RNA, Messenger | 3 | 2020 | 2552 | 0.120 |
Why?
| Cadmium | 1 | 2014 | 58 | 0.120 |
Why?
| Protein Structure, Tertiary | 2 | 2015 | 796 | 0.110 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 115 | 0.110 |
Why?
| Copper | 1 | 2014 | 100 | 0.110 |
Why?
| Glutamic Acid | 2 | 2007 | 211 | 0.110 |
Why?
| Checklist | 1 | 2014 | 83 | 0.110 |
Why?
| Pluripotent Stem Cells | 1 | 2014 | 63 | 0.110 |
Why?
| Corpus Striatum | 1 | 2014 | 126 | 0.110 |
Why?
| Brain Diseases | 1 | 2014 | 124 | 0.110 |
Why?
| Founder Effect | 1 | 2013 | 13 | 0.110 |
Why?
| Abdominal Neoplasms | 1 | 2013 | 26 | 0.110 |
Why?
| Fibroblasts | 1 | 2017 | 837 | 0.110 |
Why?
| Models, Theoretical | 1 | 2016 | 515 | 0.110 |
Why?
| Manganese Poisoning | 1 | 2012 | 1 | 0.110 |
Why?
| Parkinson Disease, Secondary | 1 | 2012 | 7 | 0.100 |
Why?
| Stem Cells | 3 | 2023 | 545 | 0.100 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 37 | 0.100 |
Why?
| Homozygote | 1 | 2013 | 187 | 0.100 |
Why?
| Genetic Testing | 1 | 2015 | 379 | 0.100 |
Why?
| Cognition | 1 | 2019 | 988 | 0.100 |
Why?
| Paired Box Transcription Factors | 1 | 2012 | 36 | 0.100 |
Why?
| Exons | 1 | 2013 | 302 | 0.100 |
Why?
| Chlorides | 1 | 2012 | 127 | 0.100 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 245 | 0.100 |
Why?
| Ribosomes | 1 | 2013 | 148 | 0.100 |
Why?
| Eye Proteins | 1 | 2012 | 70 | 0.100 |
Why?
| Fluorescent Antibody Technique | 1 | 2012 | 397 | 0.100 |
Why?
| Mice, Transgenic | 2 | 2013 | 1947 | 0.100 |
Why?
| Blotting, Western | 2 | 2012 | 1147 | 0.100 |
Why?
| SOXB1 Transcription Factors | 1 | 2012 | 60 | 0.100 |
Why?
| Adolescent | 6 | 2019 | 17831 | 0.090 |
Why?
| Blood Vessels | 1 | 2013 | 180 | 0.090 |
Why?
| Lung | 1 | 2023 | 3558 | 0.090 |
Why?
| Bone Morphogenetic Proteins | 1 | 2012 | 132 | 0.090 |
Why?
| Neovascularization, Pathologic | 1 | 2013 | 281 | 0.090 |
Why?
| Liver | 3 | 2015 | 1634 | 0.090 |
Why?
| Gene-Environment Interaction | 1 | 2012 | 183 | 0.090 |
Why?
| Quinolines | 1 | 2012 | 129 | 0.090 |
Why?
| Environmental Pollutants | 1 | 2012 | 110 | 0.090 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 398 | 0.090 |
Why?
| Cell Lineage | 2 | 2019 | 309 | 0.090 |
Why?
| gamma-Aminobutyric Acid | 1 | 2011 | 144 | 0.090 |
Why?
| Autophagy | 1 | 2013 | 233 | 0.090 |
Why?
| Cell Size | 1 | 2010 | 80 | 0.090 |
Why?
| Polyethylene Glycols | 1 | 2015 | 561 | 0.090 |
Why?
| Cell Proliferation | 1 | 2017 | 2186 | 0.090 |
Why?
| Molecular Targeted Therapy | 1 | 2013 | 347 | 0.090 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2013 | 498 | 0.090 |
Why?
| Biomedical Research | 1 | 2016 | 585 | 0.090 |
Why?
| Spinal Cord Injuries | 1 | 2013 | 174 | 0.090 |
Why?
| Embryo, Nonmammalian | 1 | 2010 | 173 | 0.090 |
Why?
| Up-Regulation | 1 | 2013 | 807 | 0.090 |
Why?
| Cell Death | 1 | 2011 | 322 | 0.090 |
Why?
| Hepatocytes | 1 | 2010 | 195 | 0.080 |
Why?
| Gene Expression Regulation | 3 | 2015 | 2319 | 0.080 |
Why?
| Behavior, Animal | 1 | 2012 | 458 | 0.080 |
Why?
| Proto-Oncogene Proteins c-myb | 3 | 1999 | 9 | 0.080 |
Why?
| Cell Cycle Proteins | 1 | 2013 | 551 | 0.080 |
Why?
| Repressor Proteins | 1 | 2012 | 366 | 0.080 |
Why?
| Pyrazoles | 1 | 2012 | 362 | 0.080 |
Why?
| Adult | 7 | 2021 | 30528 | 0.080 |
Why?
| Aging | 2 | 2023 | 1618 | 0.080 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 993 | 0.080 |
Why?
| Kidney Diseases | 1 | 2012 | 350 | 0.080 |
Why?
| Homeodomain Proteins | 1 | 2012 | 463 | 0.080 |
Why?
| Flow Cytometry | 1 | 2011 | 1083 | 0.070 |
Why?
| Glial Fibrillary Acidic Protein | 2 | 2007 | 79 | 0.070 |
Why?
| Protein Biosynthesis | 2 | 2013 | 385 | 0.070 |
Why?
| Immunohistochemistry | 1 | 2011 | 1629 | 0.070 |
Why?
| Sleep | 1 | 2012 | 631 | 0.070 |
Why?
| Mental Disorders | 1 | 2014 | 892 | 0.070 |
Why?
| DNA | 2 | 2012 | 1352 | 0.070 |
Why?
| Anxiety | 1 | 2012 | 840 | 0.070 |
Why?
| Clinical Trials as Topic | 1 | 2010 | 931 | 0.060 |
Why?
| Neuronal Plasticity | 1 | 2007 | 209 | 0.060 |
Why?
| Synaptic Transmission | 1 | 2007 | 227 | 0.060 |
Why?
| Amino Acid Motifs | 2 | 2015 | 197 | 0.060 |
Why?
| Genetic Markers | 1 | 2005 | 320 | 0.060 |
Why?
| Membrane Potential, Mitochondrial | 2 | 2014 | 55 | 0.060 |
Why?
| Hypertension, Pulmonary | 1 | 2014 | 1727 | 0.050 |
Why?
| DNA Damage | 2 | 2016 | 351 | 0.050 |
Why?
| Centrosome | 1 | 2023 | 59 | 0.050 |
Why?
| Molecular Sequence Data | 3 | 2015 | 2785 | 0.050 |
Why?
| Phosphopyruvate Hydratase | 1 | 2002 | 30 | 0.050 |
Why?
| Binding Sites | 2 | 2015 | 1168 | 0.050 |
Why?
| Genetic Predisposition to Disease | 3 | 2015 | 2084 | 0.050 |
Why?
| Nerve Tissue Proteins | 1 | 2005 | 529 | 0.050 |
Why?
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 68 | 0.050 |
Why?
| Drug Approval | 1 | 2021 | 78 | 0.050 |
Why?
| Vaccines, Synthetic | 1 | 2021 | 124 | 0.050 |
Why?
| Malformations of Cortical Development | 1 | 2020 | 7 | 0.040 |
Why?
| Stroke Volume | 1 | 2023 | 504 | 0.040 |
Why?
| Haploinsufficiency | 1 | 2020 | 42 | 0.040 |
Why?
| Advisory Committees | 1 | 2021 | 208 | 0.040 |
Why?
| Patient Advocacy | 1 | 2020 | 66 | 0.040 |
Why?
| Seizures, Febrile | 1 | 2019 | 19 | 0.040 |
Why?
| Ventricular Function, Left | 1 | 2023 | 467 | 0.040 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2019 | 26 | 0.040 |
Why?
| Cell Survival | 2 | 2013 | 1020 | 0.040 |
Why?
| Thyroid Nuclear Factor 1 | 1 | 2019 | 14 | 0.040 |
Why?
| Odontogenesis | 1 | 1999 | 10 | 0.040 |
Why?
| Culture Media | 1 | 2019 | 155 | 0.040 |
Why?
| Digestive System | 1 | 1999 | 27 | 0.040 |
Why?
| Adenosine Deaminase | 2 | 1996 | 24 | 0.040 |
Why?
| Models, Biological | 1 | 2006 | 1620 | 0.040 |
Why?
| Hair Follicle | 1 | 1999 | 44 | 0.040 |
Why?
| Kidney Tubules, Proximal | 1 | 2019 | 113 | 0.040 |
Why?
| Tamoxifen | 1 | 2019 | 191 | 0.040 |
Why?
| Thyroid Gland | 1 | 1999 | 82 | 0.040 |
Why?
| In Situ Hybridization | 1 | 1999 | 292 | 0.040 |
Why?
| Myofibroblasts | 1 | 2019 | 116 | 0.040 |
Why?
| Inhibitory Postsynaptic Potentials | 1 | 2018 | 28 | 0.040 |
Why?
| Mitosis | 1 | 1999 | 164 | 0.040 |
Why?
| Oligodendrocyte Precursor Cells | 1 | 2017 | 18 | 0.040 |
Why?
| Coculture Techniques | 1 | 2018 | 201 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2019 | 316 | 0.040 |
Why?
| Trachea | 1 | 1999 | 224 | 0.040 |
Why?
| Strategic Planning | 1 | 2016 | 3 | 0.030 |
Why?
| Zinostatin | 1 | 2016 | 1 | 0.030 |
Why?
| Nucleic Acid Synthesis Inhibitors | 1 | 2016 | 17 | 0.030 |
Why?
| Karyotyping | 1 | 2016 | 102 | 0.030 |
Why?
| Ethylnitrosourea | 1 | 2015 | 10 | 0.030 |
Why?
| Myosin Light Chains | 1 | 2015 | 26 | 0.030 |
Why?
| Diffusion | 1 | 2015 | 119 | 0.030 |
Why?
| Fluorescence Polarization | 1 | 2015 | 35 | 0.030 |
Why?
| Two-Hybrid System Techniques | 1 | 2015 | 52 | 0.030 |
Why?
| Anisotropy | 1 | 2015 | 61 | 0.030 |
Why?
| Base Sequence | 2 | 1996 | 2114 | 0.030 |
Why?
| Methylmercury Compounds | 1 | 2014 | 6 | 0.030 |
Why?
| Troponin I | 1 | 2015 | 68 | 0.030 |
Why?
| NIH 3T3 Cells | 1 | 2015 | 137 | 0.030 |
Why?
| Goals | 1 | 2016 | 147 | 0.030 |
Why?
| Introns | 1 | 1995 | 227 | 0.030 |
Why?
| Point Mutation | 1 | 1995 | 216 | 0.030 |
Why?
| Genotype | 1 | 2019 | 1760 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2015 | 353 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 313 | 0.030 |
Why?
| United States | 3 | 2021 | 12176 | 0.030 |
Why?
| Protein Isoforms | 1 | 2015 | 338 | 0.030 |
Why?
| Axons | 1 | 2015 | 177 | 0.030 |
Why?
| Myocardial Contraction | 1 | 2015 | 313 | 0.030 |
Why?
| Familial Primary Pulmonary Hypertension | 1 | 2014 | 190 | 0.030 |
Why?
| Mice, Nude | 1 | 2015 | 630 | 0.030 |
Why?
| Terminology as Topic | 1 | 2014 | 187 | 0.030 |
Why?
| Genes, Lethal | 1 | 2013 | 26 | 0.030 |
Why?
| RNA, Ribosomal, 18S | 1 | 2013 | 21 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2015 | 385 | 0.030 |
Why?
| Manganese Compounds | 1 | 2012 | 3 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2020 | 2537 | 0.030 |
Why?
| HEK293 Cells | 1 | 2015 | 591 | 0.030 |
Why?
| Biomechanical Phenomena | 1 | 2015 | 668 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1691 | 0.030 |
Why?
| Neurologic Examination | 1 | 2012 | 114 | 0.030 |
Why?
| PAX6 Transcription Factor | 1 | 2012 | 18 | 0.020 |
Why?
| Respiratory Mucosa | 1 | 2014 | 251 | 0.020 |
Why?
| Young Adult | 2 | 2018 | 10455 | 0.020 |
Why?
| Middle Aged | 3 | 2019 | 26719 | 0.020 |
Why?
| Homeostasis | 2 | 2007 | 573 | 0.020 |
Why?
| Saccharomyces cerevisiae | 1 | 1995 | 476 | 0.020 |
Why?
| Age Factors | 1 | 1999 | 2894 | 0.020 |
Why?
| Pregnancy | 1 | 2023 | 5517 | 0.020 |
Why?
| Biosensing Techniques | 1 | 2012 | 100 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2015 | 1982 | 0.020 |
Why?
| Neural Inhibition | 1 | 2012 | 140 | 0.020 |
Why?
| Phosphorylation | 1 | 2014 | 1569 | 0.020 |
Why?
| Risk Factors | 2 | 2014 | 8628 | 0.020 |
Why?
| Models, Molecular | 1 | 2015 | 1369 | 0.020 |
Why?
| Reactive Oxygen Species | 1 | 2012 | 531 | 0.020 |
Why?
| Pilot Projects | 1 | 2014 | 1372 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2019 | 4689 | 0.020 |
Why?
| Protein Binding | 1 | 2015 | 1889 | 0.020 |
Why?
| Infant, Newborn | 1 | 2019 | 5043 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 1842 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2015 | 2762 | 0.020 |
Why?
| T-Lymphocytes | 1 | 1995 | 1736 | 0.020 |
Why?
| Nerve Degeneration | 1 | 2007 | 40 | 0.020 |
Why?
| Neocortex | 1 | 2007 | 24 | 0.020 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2007 | 87 | 0.020 |
Why?
| Organ Culture Techniques | 1 | 2007 | 140 | 0.020 |
Why?
| Long-Term Potentiation | 1 | 2007 | 145 | 0.020 |
Why?
| Case-Control Studies | 1 | 2012 | 3003 | 0.020 |
Why?
| Treatment Outcome | 1 | 2018 | 9084 | 0.010 |
Why?
| Biological Transport, Active | 1 | 2003 | 71 | 0.010 |
Why?
| Gliosis | 1 | 2003 | 29 | 0.010 |
Why?
| Electrophysiology | 1 | 2003 | 201 | 0.010 |
Why?
| Hippocampus | 1 | 2007 | 693 | 0.010 |
Why?
| Time Factors | 1 | 2012 | 6112 | 0.010 |
Why?
| Retrospective Studies | 1 | 2018 | 12542 | 0.010 |
Why?
| Immunoenzyme Techniques | 1 | 2002 | 192 | 0.010 |
Why?
| Synapses | 1 | 2003 | 330 | 0.010 |
Why?
| Aged | 1 | 2016 | 19061 | 0.010 |
Why?
| Awards and Prizes | 1 | 1996 | 56 | 0.010 |
Why?
| Hematopoiesis | 1 | 1996 | 171 | 0.010 |
Why?
| Societies, Medical | 1 | 1996 | 663 | 0.010 |
Why?
| Biomarkers | 1 | 2002 | 3408 | 0.010 |
Why?
|
|
Ess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|